UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549~~

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the ~~Securities Exchange Act of 1934~~

~~Date~~Securities ofExchange ~~Report~~Act ~~(date~~ of ~~earliest event reported): August 23, 2024~~1934

~~AMERICANN,~~Date ~~INC.~~of Report (~~Exact~~date ~~name~~ of ~~registrant~~earliest asevent ~~specified~~reported): inAugust ~~its~~27, ~~charter)~~2024

AMERICANN, INC.

(Exact name of Registrant as specified in its charter)

	Delaware		000-54231		27-4336843
	(State or other jurisdiction of incorporation)		(Commission File No.)		(IRS Employer Identification No.)

1555 Blake Street, Unit 502 ~~Denver, CO 80216~~

Denver, CO 80202

(Address of principal executive offices, including Zip Code)

Registrant'’s telephone ‐‐number, including area code: (303) 862-9000

Nevada Health Scan, Inc.

(Former name or former address if changed since last report)

Check ~~the~~ appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: (see General Instruction A.2. below)

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		N/A		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 23, 2024 J. Tyler Opel ~~resigned~~stepped down as a director of the Company. Mr. Opel’s ~~resignation~~departure was not the result of any disagreement concerning the Company’s operations, policies or practices.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 2328, 2024

	AMERICANN, INC.


	By:	/s/ Timothy Keogh
		Timothy Keogh, Chief Executive Officer

Filing Compare · AmeriCann, Inc.